Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

LeanDose vs MedLeanRx

LeanDose
Graded #175

Lower grade

vs+6.800000000000011
MedLeanRx
Graded #69

Higher grade

The verdict

MedLeanRx takes it — 73.9/100 to 67.1/100.

MedLeanRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. MedLeanRx is a physician-guided telehealth weight-loss clinic serving Texas only, based in Spring, TX.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueMedLeanRx +8
66
74
Dose & formulationMedLeanRx +29
64
93
Clinical oversightLeanDose +2
79
77
Labs & monitoringLeanDose +2
54
52
FulfillmentLeanDose +2
79
77
Contract termsEven
55
55
LeanDose · left barMedLeanRx · right bar

The numbers

MetricLeanDoseMedLeanRx
WeighScore67.1/10073.9/100
GradeCC
Scorecard rank#175#69
Semaglutide$159/mo (first-month rate, compounded)$149/mo (starting dose, promotional rate, compounded)
Tirzepatide$279/mo (first-month rate, compounded)$269/mo (starting dose, compounded)
CoverageCoverage not published1 states
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyYes
LeanDose

Graded #175 · C

Strengths

  • Transparent all-inclusive first-month pricing (compounded semaglutide from $159, tirzepatide from $279)
  • Verifiable LegitScript certification (seal ID 49840868) and an FDA-registered compounding pharmacy
  • Doctor-prescribed and supervised, with personalized care plans and multi-state clinical support
  • Convenient at-home delivery; compounded semaglutide and tirzepatide options
  • Honest, modest social proof — 119 five-star patient reviews

Where it loses points

  • Compounded medications are not FDA-approved — not brand Wegovy, Ozempic, Zepbound, or Mounjaro
  • Headline rates are first-month pricing; your ongoing monthly cost may be higher
  • Available in multiple states but the full list is not published on the homepage
  • The compounding pharmacy is FDA-registered but not named
MedLeanRx

Graded #69 · C

Strengths

  • Compounded semaglutide $149/mo in both weekly injection and daily oral tablet form
  • Brand pathway for Wegovy, Zepbound, and Foundayo (orforglipron) at a $99/mo fee plus medication cost
  • Intro bundle: 2 months of compounded tirzepatide (2 mg weekly) for $325 — about $163/mo
  • LegitScript seal displayed; named supervising physician (Dr. Johnson Uzor, MD)
  • Free shipping, no hidden fees, and cancel-anytime plans per homepage trust chips

Where it loses points

  • Texas only — not available in the other 49 states
  • Compounded tirzepatide is $269/mo at standard pricing, above the ~$249 market median
  • Strict no-refund policy: 'All sales are final' per Terms & Conditions
  • Pharmacy partner not publicly named — a transparency gap for a compounding service
  • Legal entity name and founding details not published on the site

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard